Article written by Ginny Fisher, RN, BSN, CCM, Managed Care Specialist for Summit Reinsurance Services, Inc
Ongoing monitoring follows product-specific guidance and NICE recommendations: For semaglutide (Wegovy): Assess at 6 months after reaching maintenance dose
Illnesses concurrent with the MMR vaccine were nine times more likely in autistic children when all cases were considered, and 17 times more likely after limiting cases to children who regressed
Stored this way, most lyophilized peptides remain stable for 24 months or longer
So I think recognizing that youre kind of in a losing position from the start against that environment is realistic, and its a good sort of first step
Usually, these FDA panels are composed of academics and researchers